VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog๐ŸคPartner
Illustration for: Anthropic and OpenAI's Parallel Paths to Going Public
Value Add VC/Pulse/IPODEEP DIVE

Anthropic and OpenAI's Parallel Paths to Going Public

Anthropic and OpenAI both have draft S-1s in motion, but their public postures differ sharply -- Anthropic racing toward a size comparable to SpaceX, OpenAI's CFO explicitly declining to treat the process as a race.

By the Numbers

filed June 1, 2026
Anthropic confidential S-1
$65B annualized
Anthropic July run rate
match/beat $86.2B
Anthropic target size
not racing to list
OpenAI stance
SpaceXSPCXAnthropicOpenAI
TC
By the IPO Desk
Edited by Trace Cohen ยท Early-stage VC & angel ยท Founder, New York Venture Partners
August 21, 2026
2 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Anthropic and OpenAI both have draft S-1 filings in motion with the SEC at the same time, but the two companies' public posture toward their own IPO timelines reads very differently -- Anthropic [pushing to match or exceed SpaceX's record IPO size](/pulse/anthropic-ipo-matches-spacex-record-size-2026), OpenAI's CFO Sarah Friar publicly declining to frame the process as a race against Anthropic

2

Anthropic's push is grounded in disclosed momentum: a $65B annualized revenue run rate as of July, up from roughly $9B in late 2025, and a CFO already leading early investor meetings ahead of a possible public filing by the end of August

3

OpenAI's more measured public posture doesn't necessarily mean a later listing -- it may simply reflect a company managing investor and public expectations differently while its own confidential S-1 process continues in parallel, largely outside public reporting

4

Whichever company files and lists first will set the market's first real read on how public investors price a frontier AI lab at scale, a comparison point the other company's own eventual roadshow will be measured against regardless of how either company frames the relationship publicly

TC

The VC Read ยท Trace's Take

Trace Cohen

Anthropic committing publicly to a SpaceX-matching size is the higher-variance play -- it sets a bar the market will hold the company to on day one, while OpenAI's 'not racing' framing buys Sarah Friar room to manage expectations either up or down depending on where conditions sit when OpenAI actually files. If I had to bet on which company's stock has the rockier first ninety days, I'd bet on whichever one over-committed to a specific number now, and right now that's Anthropic.

Tech IPO Tracker โ†’

Analysis

Anthropic and OpenAI both have draft S-1 filings in motion with the SEC at the same time this year, per Pulse's own IPO tracking, but the two companies' public posture toward their own IPO timelines could hardly read more differently.

Anthropic: racing toward a specific, enormous benchmark

Anthropic's public trajectory has been unusually aggressive in signaling scale. The company confidentially filed its draft S-1 on June 1, working with Morgan Stanley, Goldman Sachs and JPMorgan, and by mid-August CFO Krishna Rao was already leading early investor meetings ahead of a possible public filing by the end of the month. The company's stated ambition -- to match or exceed SpaceX's record $86.2 billion raise -- is grounded in disclosed operating momentum: a $65 billion annualized revenue run rate as of July, up roughly sevenfold from late 2025, with some investors modeling a valuation above $2 trillion based on that growth trajectory, though Anthropic itself hasn't confirmed a specific number.

โ€œ## OpenAI: a more measured public posture OpenAI's own confidential S-1 process has drawn far less public signaling around size or timeline.โ€

OpenAI: a more measured public posture

OpenAI's own confidential S-1 process has drawn far less public signaling around size or timeline. CFO Sarah Friar has said publicly that OpenAI isn't racing to beat Anthropic to market -- a notably different framing from Anthropic's own explicit SpaceX-scale ambition. That doesn't necessarily mean OpenAI's listing will actually come later; a company can be further along in its confidential filing process than its public statements suggest, and declining to frame the situation as competitive is itself a communications choice that doesn't reveal much about the underlying timeline.

Why the difference in posture matters

The two companies' different public framing likely reflects different strategic calculations about what serves each of them best heading into a roadshow. Anthropic explicitly targeting a SpaceX-matching size creates its own pressure -- investors will hold the company to that benchmark once it's public, and falling meaningfully short could read as a disappointment even if the actual raise is still enormous by any conventional measure. OpenAI's more understated posture leaves more room to manage expectations upward without having pre-committed to a specific record-breaking target.

What the eventual first-mover gets, and risks

Whichever company files and completes its IPO first will set the market's first real test of how public investors price a frontier AI lab at the scale both companies now operate. That first pricing becomes an unavoidable comparison point for whichever company lists second, regardless of how either company frames the relationship publicly now -- a strong debut from the first mover raises the bar for the second; a disappointing one invites skepticism the second company will have to actively work to overcome.

The counterweight

Both companies' confidential S-1 processes remain subject to change, and neither has committed to a specific public filing date -- Anthropic's "as soon as the end of August" timeline and OpenAI's more open-ended posture could both slip for reasons unrelated to either company's actual readiness, from market conditions to regulatory review timing. It's also worth treating the SpaceX-scale comparison skeptically on its own terms: Pulse has covered how SpaceX's own stock dipped below its IPO price within weeks of its record-setting debut, a reminder that matching a record IPO size on day one says nothing about where either Anthropic or OpenAI's stock actually trades months later.

Related Deep Dives

  • OpenAI vs Anthropic Revenue Dispute: $74B Gross ARR vs $4... โ†’
  • xAI Valuation 2026: The $230B Series E, the $1.25T SpaceX... โ†’
  • $965B Anthropic โ€” $47B Run Rate & IPO Filing Explained โ†’
ShareXLinkedInEmail

More on

SpaceX โ†’Anthropic โ†’OpenAI โ†’

Prior Pulse Coverage

SpaceXAnthropic's IPO Filing Will Flag AI Backlash as RiskAnthropicAnthropic Opens Its Hacker-Grade AI to More DefendersSpaceXAnthropic Eyes IPO Big Enough to Beat SpaceXAnthropic2026 US IPO Volume Nears the 2021 RecordAnthropicMassachusetts AI Bill Pits Anthropic Against OpenAI

Key Sources

2 sources
SourceValue Add Pulse Analysis
AnalysisValue Add Pulse

Reported by Value Add Pulse Analysis ยท Analysis by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPOยท Aug 21, 2026

Anthropic's IPO Filing Will Flag AI Backlash as Risk

Illustration for: Anthropic's IPO Filing Will Flag AI Backlash as Risk
IPO

Anthropic's IPO Filing Will Flag AI Backlash as Risk

Anthropic's forthcoming IPO filing will include AI backlash -- public and regulatory skepticism toward the industry -- as a formal risk factor, sources tell CNBC, an unusually candid disclosure for a company chasing SpaceX's record size.

IPOยท Aug 21, 2026

Three SPACs File This Week Hunting for Targets

Illustration for: Three SPACs File This Week Hunting for Targets
IPO

Three SPACs File This Week Hunting for Targets

Dune Acquisition Corp III, Albatross Acquisition Corp and Three Lions Acquisition Corp all filed amended S-1 registrations this week, adding to a modest but real pipeline of blank-check vehicles still working through the SEC process.

IPOยท Aug 21, 2026

Three Biotechs File S-1s in the Same Week

Illustration for: Three Biotechs File S-1s in the Same Week
IPO

Three Biotechs File S-1s in the Same Week

Tempest Therapeutics, Aptevo Therapeutics and Alzamend Neuro all filed S-1 registration statements this week, a reminder that the biotech IPO pipeline keeps moving even in a news cycle dominated by trillion-dollar AI listings.

Deep Dives

OpenAI vs Anthropic Revenue Dispute: $74B Gross ARR vs $4...xAI Valuation 2026: The $230B Series E, the $1.25T SpaceX...$965B Anthropic โ€” $47B Run Rate & IPO Filing Explained
@Trace_Cohenยทt@nyvp.com